Siempre nos quedará el lorazepam
La repentina popularidad del medicamento recetado para la ansiedad es una señal de la obsesión de los fans con Victoria Ratliff, personaje de “The White Lotus”.
Boston Faces Identity Crisis Amid Trump’s Cuts to University and Research Funding
Colleges and teaching hospitals are the cornerstones of the city’s economy — and identity. But federal funding cuts to higher education could change that.
After “The White Lotus,” Lorazepam Lives On in Memes and Merch
“The White Lotus” Season 3 may be ending, but the medication that has become synonymous with it has found a new life in memes and merchandise.
Trump Rejects Proposal for Medicare to Cover Wegovy and Other Obesity Drugs
Administration officials reversed a decision made during the Biden presidency that would have given millions of people access to weight-loss drugs paid for Medicare and Medicaid.
Trump’s Next Tariffs Target Could be Foreign-Made Pharmaceuticals
President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result in shortages and higher prices for generic drugs.
FDA Layoffs Could Raise Drug Costs and Erode Food Safety
Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who advance generic drug approvals were also dismissed.
La derecha en EE. UU. sigue defendiendo a la ivermectina
El fármaco se ha convertido en una especie de símbolo de resistencia a lo que algunos en el movimiento MAGA describen como una élite corrupta.
‘Natty or Not’ Influencer Kenny Boulet Wants People to Be More Honest About Steroids
The fitness influencer Kenny Boulet, who asks gymgoers if they’re “natty or not,” wants people to be more honest about their steroid use.
Why the Right Still Embraces Ivermectin
Five years after the pandemic began, interest in the anti-parasitic drug is rising again as right-wing influencers promote it — and spread misinformation about it.
Isomorphic Labs, Google’s A.I. Drug Business, Raises Money From Thrive
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital as a backer.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.